期刊文献+

HCVRNA载量在慢性丙肝、肝硬化、肝癌患者中的变化及基因分型 被引量:6

The hepatitis C virus( HCV) RNA load changes in chronic hepatitis C、HCV-related liver cirrhosis and HCV- related hepatocellular carcinoma groups and genotype effects on disease progression
原文传递
导出
摘要 目的了解丙型肝炎病毒RNA(HCVRNA)载量在慢性丙型肝炎、丙型肝炎肝硬化、丙肝相关的肝癌(HCV-HCC)患者中的变化及基因分型对疾病进展的影响。方法回顾性分析2010年2月至2013年8月门诊及住院的1 386例HCVRNA阳性且未进行抗病毒治疗的丙型肝炎患者的临床病例资料,把患者按诊断分为丙型肝炎组、丙肝肝硬化组、丙肝相关的肝癌组,采用qRT-PCR检测患者血清的HCVRNA载量与基因分型,多组比较采用方差分析或卡方检验,两组间比较采用t检验。结果丙型肝炎组、丙肝肝硬化组及丙肝相关的肝癌组患者HCVRNA载量分别为(6.47±1.03)lg IU/mL,(6.18±1.09)lg IU/mL和(6.07±1.13)lg IU/mL,三组患者HCVRNA载量不同,丙型肝炎组HCVRNA明显高于其他二种,且差别有统计学意义(F=12.80,P<0.05),但丙肝肝硬化组与HCV-HCC组患者HCVRNA载量差别无统计学意义(t=0.65,P>0.05)。1 386例患者中816例进行了HCV基因型检测,1型基因型529例(64.83%),2型基因型287例(35.17%),丙型肝炎组患者1型基因型者为400例,2型基因型者为226例,1b型基因型为主(63.10%),丙肝肝硬化组1型基因型117例,2型基因型为57例,1b型基因型为主(65.52%),HCV-HCC组1型基因型为12例,2型基因型为4例,1b型基因型为主(68.75%),三组患者基因型比例无明显差别(χ2=1.02,P=0.31)。结论 HCVRNA载量在慢性丙型肝炎发展为肝硬化、肝癌的过程中减低,河南地区丙肝患者以1型基因型为主,且1型、2型基因型对疾病的进展没有影响。 Objective To evaluate the hepatitis C virus(HCV) RNA load changes in chronic hepatitis C,HCV -related liver cirrhosis and HCV - related hepatocellular carcinoma groups and the genotype effects on disease progression. Methods Totally 1386 patients from inpatient and outpatient department of our hospital whose HCVRNA is positive and not receive antiviral therapy were retrospectively analyzed from Feb 2010 to Aug 2013, these patients were divided into three groups according to the diagnosis : Chronic hepatitis C group, HCV - related liver cirrhosis group, HCV - relat- ed hepatoeellular carcinoma group. The HCVRNA load and genotype of the HCV were analyzed by quantitative real - time polymerase chain reaction( qRT - PCR). Multiple groups were compared using analysis of variance or chi - square test,the comparison between the two groups using the t test. Results The HCVRNA load of the chronic hepatitis C group, HCV - related liver cirrhosis group and HCV - related hepatocellular carcinoma group were ( 6. 47 ± 1.03 ) lg IU/ mL, (6. 18 ± 1.09 ) lg IU/mL and (6.07 ± 1.13 ) lg IU/mL, respectively, which demonstrated that the HCVRNA load in chronic hepatitis C group was much higher than that of the other two groups (F = 12. 80, P 〈 0. 05 ). But no significant difference of HCVRNA load was found between HCV - related liver cirrhosis and HCV - related hepatocellular carcinoma group ( t = 0. 65,P 〉 0. 05 ) ; Of the 1386 included patients, 816 cases was analyzed for genotype. Type 1 genotype was 529 cases(64. 83% ) ,type 2 genotype was 287 cases(35.17% ) ,In the hepatitis C group,there was 400 patients with type 1 genotype and 226 cases with type 2 genotype which demonstrated type 1 b genotype dominated (63.10%). In the hepatitis C cirrhosis group, there was 117 patients with type 1 genotype and 57 cases with type 2 genotype which demon- strated type l b genotype dominated(65.52% ). In the HCV -related hepatocellular carcinoma group, there was 12 pa- tients with type lb genotype and 4 cases with type 2a genotype which demonstrated type lb genotype dominated ( 68.75 % ). There was no statistical difference distribution of the genotype among the three groups ( X2 = 1.02, P = 0. 31 ) Conclusion The HCV RNA load in the procedure of patients with chronic hepatitis C developing cirrhosis and hepato- cellular carcinoma was decreased. The type 1 genotype of HCV was dominant in Henan Province,genotype 1 and 2 have no effect on the progression of the disease.
出处 《医药论坛杂志》 2014年第2期47-49,共3页 Journal of Medical Forum
关键词 丙型肝炎 丙肝病毒RNA载量 肝硬化 肝癌 基因分型 Hepatitis c HCV RNA load Liver cirrhosis Hepatocellular carcinoma Genotype
  • 相关文献

参考文献4

  • 1Soriano Y, Vispo E, Fernandez - Montero JV, et al. Update onHIV/HCV coinfection[J]. Curr HIV/AIDS Rep,2013 ,10 ( 3 ):226-34.
  • 2Karoney MJ,Siika AM. Hepatitis C virus( HCV) infection in Af-rica: a review[J]. Pan Afr Med J,2013,14: 44.
  • 3Cobb B,Pockros PJ,Vilchez RA,et al. HCV RNA viral load as-sessments in the era of direct - acting antivirals[J]. Am J Gas-troenterol, 2013 ,108(4) :471 -5.
  • 4裴彦祯,韩涛,马晓艳,李莹,邢晶,宋佐莉.HBsAg及HBVDNA定量水平在慢性乙型肝炎、肝硬化和肝癌患者中的变化[J].中华肝脏病杂志,2011,19(10):743-746. 被引量:53

二级参考文献11

  • 1原发性肝癌的临床诊断与分期标准[J].肝脏,2004,9(S1):67-68. 被引量:52
  • 2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 3Ganem D, Prince AM. Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med, 2004, 350: 1118-1129.
  • 4Ismail N, Fish GE, Smith MB. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus. J Clin Microbiol, 2004, 42:610-617.
  • 5Wong DK, Yuen MF, Poon RT, et al. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. J Hepatol, 2006, 45: 553-559.
  • 6Thompson AJ, Nguyen T, Iser D, et al. Senlm hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology, 2010, 51: 1933-1944.
  • 7Jaroszewicz J, Calle Serrano B, Wursthorn K, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B vires (HBV)-infection: a European perspective. J Hepatol, 2010, 52: 514-522.
  • 8Nguyen T, Thompson AJ, Bowden S, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol, 2010, 52:508-513.
  • 9Galli C, Orlandini E, Penzo L, et al. What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology? J Med Virol, 2008, 80: 974-999.
  • 10Wursthorn K, Lutgehetmann M, Dandri M, et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology, 2006, 44: 675-684.

共引文献52

同被引文献61

  • 1樊和斌,郭亚兵,杨洁,侯金林,王战会,朱幼芙,秦劲峰.慢性乙型肝炎患者HBV基因型及其临床意义[J].第一军医大学学报,2005,25(2):229-230. 被引量:15
  • 2于春光,王天芳,万霞,赵燕,李志更,尹英杰,张秋云,胡立胜,王庆国.慢性乙型肝炎常见中医证候及证候要素的分析[J].北京中医药大学学报,2005,28(6):70-73. 被引量:34
  • 3应豪,周文红.常用血清学指标与慢性乙型肝炎肝纤维化程度相关性研究[J].中西医结合肝病杂志,2007,17(1):10-11. 被引量:18
  • 4宋玉国,郑艳,黄建文,王晓光,张吉林,李若伦.HCV基因型与HCV感染者ALT的关系[J].中国实验诊断学,1997,1(2):29-30. 被引量:5
  • 5刘丽君,魏来.丙型肝炎病毒的流行病学[J].传染病信息,2007,20(5):261-264. 被引量:72
  • 6陈建杰,聂红明,王成宝,等.中国慢性丙型肝炎中医证候的多中心、大样本流行病学研究[C].中华中医药学会全国第十四次肝胆病学术会议论文汇编,2010.
  • 7Yu ML, Chuang WL. Treatment of chronic hepatitis C in Asia: When East meets West [ J ]. Journal of Gastroenterology and Hepatology, 2009, 24:336 - 345.
  • 8Ferenci P. Predictors of response to therapy for chronic hepatitis C [J]. Semin Liver Dis 2004, 24: Suppl 2:25 -31.
  • 9Omata? M, Kanda T, Yu ML et. al. APASL consensus state- ments and management algorithms for hepatitis C virus infection [ J]. Hep- atology International, 2012, 6 : 409 - 435.
  • 10翟嵩,王媛,党双锁,等.慢性丙肝患者血浆Th17/IFN-γ水平同干扰素抗病毒治疗快速应答相关性研究[C]//中华医学会感染病学分会.中华医学会第十三次全国感染病学术会议论文汇编.广州:中华医学会感染病学分会,2014:1.

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部